TRAUMAKINE

Class [005]
Pharmaceutical preparations for treatment and prevention of ischemic conditions resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions, namely, arthritis, ocular inflammatory conditions, inflammatory connective tissue diseases and injuries, inflammatory pelvic disease, inflammatory muscle diseases and disorders conditions, and allergic conditions; Pharmaceutical preparations for treatment and prevention of inflammation resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions, namely, arthritis, ocular inflammatory conditions, inflammatory connective tissue diseases and injuries, inflammatory pelvic disease, inflammatory muscle diseases and disorders conditions, and allergic conditions; Pharmaceutical preparations for treatment and prevention of organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions, namely, arthritis, ocular inflammatory conditions, inflammatory connective tissue diseases and injuries, inflammatory pelvic disease, inflammatory muscle diseases and disorders conditions, and allergic conditions; Pharmaceutical preparations for treatment and prevention of multi-organ failure, and acute lung injury and acute respiratory distress syndrome in adults, adolescents, children, infants and neonates; Anti-infectives; Anti-inflammatory preparations; Anti-viral agents; Antiviral pharmaceutical preparations; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical antibody preparations for auto-immune diseases; Pharmaceutical antibody preparations for respiratory disease; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases, namely inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of the respiratory system; Pharmaceutical preparations for the treatment of vascular diseases; Pharmaceutical preparations for use in immunomodulation therapies; Pharmaceutical preparations for use in immunotherapies; Pharmaceutical preparations for use in the treatment of autoinflammatory diseases; Pharmaceutical preparations for use in the treatment of immunological disorders; Pre-filled syringes with pharmaceutical preparations for treating auto-immune diseases; Vaccine adjuvants.